Philip Morris International to Present at 2024 CAGNY Conference
February 14 2024 - 7:37AM
Business Wire
Regulatory News:
Philip Morris International Inc. (PMI) (NYSE: PM) will host a
live audio webcast of a presentation by Jacek Olczak, Chief
Executive Officer, and Emmanuel Babeau, Chief Financial Officer, at
the Consumer Analyst Group of New York (CAGNY) Conference on
Wednesday, February 21, 2024, at 10:00 a.m. ET.
The live webcast and presentation slides will be available at
www.pmi.com/2024cagny. The webcast replay will be available at the
same link until Friday, March 22, 2024.
The webcast may also be accessed on mobile devices by
downloading PMI’s Investor Relations App at www.pmi.com/irapp.
Philip Morris International: Delivering a Smoke-Free
Future
Philip Morris International (PMI) is a leading international
tobacco company, actively delivering a smoke-free future and
evolving its portfolio for the long term to include products
outside of the tobacco and nicotine sector. The company’s current
product portfolio primarily consists of cigarettes and smoke-free
products. Since 2008, PMI has invested $12.5 billion to develop,
scientifically substantiate and commercialize innovative smoke-free
products for adults who would otherwise continue to smoke, with the
goal of completely ending the sale of cigarettes. This includes the
building of world-class scientific assessment capabilities, notably
in the areas of pre-clinical systems toxicology, clinical and
behavioral research, as well as post-market studies. In 2022, PMI
acquired Swedish Match – a leader in oral nicotine delivery –
creating a global smoke-free champion led by the companies’ IQOS
and ZYN brands. The U.S. Food and Drug Administration has
authorized versions of PMI’s IQOS Platform 1 devices and
consumables and Swedish Match’s General snus as Modified Risk
Tobacco Products. As of December 31, 2023, PMI's smoke-free
products were available for sale in 84 markets, and PMI estimates
that approximately 20.8 million adults around the world had already
switched to IQOS and stopped smoking. Smoke-free products accounted
for approximately 37% of PMI’s total full-year 2023 net revenues.
With a strong foundation and significant expertise in life
sciences, PMI announced in February 2021 its ambition to expand
into wellness and healthcare areas and, through its Vectura Fertin
Pharma business, aims to enhance life through the delivery of
seamless health experiences. For more information, please visit
www.pmi.com and www.pmiscience.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240214234523/en/
Philip Morris International Investor Relations: Stamford,
CT: +1 (203) 905 2413 Lausanne: +41 (0) 58 242 4666 Email:
InvestorRelations@pmi.com Media: David Fraser Lausanne: +41 (0)58
242 4500 Email: David.Fraser@pmi.com
Philip Morris (NYSE:PM)
Historical Stock Chart
From May 2024 to Jun 2024
Philip Morris (NYSE:PM)
Historical Stock Chart
From Jun 2023 to Jun 2024